cobas liat SARS-CoV-2 v2 Nukleïensuurtoets: CLIA-vrystellingsbesluitopsomming
Summary of the CLIA waiver approval determination for the cobas liat SARS-CoV-2 v2 nucleic acid test by Roche Molecular Systems, Inc. This document details the test's performance characteristics, system components,…